Figure 3From: Clinical and pathologic factors associated with survival in young adult patients with fibrolamellar hepatocarcinomaGlobal survival of patients with FLC at 6, 12, 24, 36 and 60 months was 66, 66, 53, 40 and 26% (median survival of 30 ± 6 months).Back to article page